Proarrhythmia Risk Assessment Using Electro-Mechanical Window in Human iPS Cell-Derived Cardiomyocytes

Chemical Compounds

• Bepridil 98%
• Dofetilide 68%
• Drug 9%
• Mexiletine 89%
• QT Interval 35%
• Ranolazine 100%
• Risk Assessment 66%

Medicine & Life Sciences

• Aspirin 12%
• Bepridil 32%
• Cardiac Myocytes 50%
• Cardiotoxicity 7%
• Clinical Studies 4%
• dofetilide 21%
• Drug Evaluation 8%
• Electrodes 5%
• Ether 7%
• In Vitro Techniques 17%
• Induced Pluripotent Stem Cells 61%
• Mexiletine 30%
• Pharmaceutical Preparations 5%
• Ranolazine 32%
• Risk Assessment 45%
• Torsades de Pointes 72%
• Validation Studies 7%